臨床外科65巻11号

2010年10月発行

特集 外科医のための大腸癌の診断と治療 3．特殊な大腸癌の病態と治療方針

リンチ症候群

著者： 松原長秀¹

所属機関： ¹兵庫医科大学下部消化管外科

ページ範囲：P.132 - P.139

■診断には，まずベセスダ診断基準をもとに疑い患者を拾い上げる．

■つぎに，保険収載されたMSIテストで陽性であれば遺伝子検査を行う．

■関連癌の発見には臨床症状を逃さないことが重要である．

参考文献

1）Bashford EF. Heredity in cancer. Lancet 2：1508-1512, 1908

2）Warthin AS：Hereditary with reference to carcinoma. Arch Intern Med 12：546-555, 1913

3）Warthin AS：The further study of a cancer family. J Cancer Res 9：278-286, 1925

4）Hauser JJ, Weller CV：A further report on the cancer family of Warthin. Am J Cancer 27：434-449, 1936

5）Lynch HT, Krush AJ：Cancer family“G”revisited：1895-1970. Cancer 27：1505-1511, 1971

6）Fishel R, Lescoe MK, Rao MR, et al：The human mutator gene homolog MSH2 and its association with hereditary nonpolyposis colon cancer. Cell 75：1027-1038, 1993

7）Leach FS, Nicolaides NC, Papadopoulos N, et al：Mutations of a mutS homolog in hereditary nonpolyposis colorectal cancer. Cell 75：1215-1225, 1993

8）Papadopoulos N, Nicolaides NC, Wei YF, et al：Mutation of a mutL homolog in hereditary colon cancer. Science 263：1625-1629, 1994

9）Bronner CE, Baker SM, Morrison PT, et al：Mutation in the DNA mismatch repair gene homologue hMLH1 is associated with hereditary non-polyposis colon cancer. Nature 368：258-261, 1994

10）Kolodner RD：Mismatch repair：mechanisms and relationship to cancer susceptibility. Trends Biochem Sci 20：397-401, 1995

11）Vasen HF, Mecklin JP, Khan PM, et al：The International Collaborative Group on Hereditary Non-Polyposis Colorectal Cancer（ICG-HNPCC）. Dis Colon Rectum 34：424-425, 1991

12）Vasen HF, Watson P, Mecklin JP, et al：New clinical criteria for hereditary nonpolyposis colorectal cancer（HNPCC, Lynch syndrome）proposed by the International Collaborative group on HNPCC. Gastroenterology 116：1453-1456, 1999

13）Hampel H, Frankel WL, Martin E, et al：Screening for the Lynch syndrome（hereditary nonpolyposis colorectal cancer）. N Engl J Med 352：1851-1860, 2005

14）Rodriguez-Bigas MA, Boland CR, Hamilton SR, et al：National Cancer Institute Workshop on Hereditary Nonpolyposis Colorectal Cancer Syndrome：meeting highlights and Bethesda guidelines. J Natl Cancer Inst 89：1758-1762, 1997

15）Boland CR, Thibodeau SN, Hamilton SR, et al：A National Cancer Institute Workshop on Microsatellite Instability for cancer detection and familial predisposition：development of international criteria for the determination of microsatellite instability in colorectal cancer. Cancer Res 58：5248-5257, 1998

16）Umar A, Boland CR, Terdiman JP, et al：Revised Bethesda Guidelines for hereditary nonpolyposis colorectal cancer（Lynch syndrome）and microsatellite instability. J Natl Cancer Inst 96：261-268, 2004

17）Barnetson RA, Tenesa A, Farrington SM, et al：Identification and survival of carriers of mutations in DNA mismatch-repair genes in colon cancer. N Engl J Med 354：2751-2763, 2006

18）de Vos tot Nederveen Cappel WH, Buskens E, van Duijvendijk P, et al：Decision analysis in the surgical treatment of colorectal cancer due to a mismatch repair gene defect. Gut 52：1752-1755, 2003

19）Lindor NM, Rabe K, Petersen GM, et al：Lower cancer incidence in Amsterdam-I criteria families without mismatch repair deficiency：familial colorectal cancer type X. JAMA 293：1979-1985, 2005

20）Lightenberg MJ, Kuiper RP, Chan TL, et al：Heritable somatic methylation and inactivation of MSH2 in families with Lynch syndrome due to deletion of the 3' exons of TACSTD1. Nat Genet 41：112-117, 2009